Macular degeneration: open trials in Spain

23 open trials have a site in Spain. Registry data; only the trial team decides who can take part.

NCT06847542
A Study of 36-Week Refill Exchanges of Port Delivery System (PDS) With Ranibizumab in nAMD
Trial Treatment · Phase 3 · Hoffmann-La Roche
Hospital Universitario Fundación Jiménez Díaz, Madrid · Hospital Universitario La Paz, Madrid · University Hospital Virgen Del Rocio S.L., Sevilla · Hospital Arnau de Vilanova de Valencia, Valencia
Registry updated 2026-11-06
NCT06541704
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
Trial Treatment · Phase 3 · Regeneron Pharmaceuticals
Instituto De Microcirugia Ocular Dos S.L., Barcelona · Institut Catala De Retina S.L., Barcelona · Centro De Oftalmologia Barraquer S.A., Barcelona · Oftalmologia Vistahermosa S.L., Burjassot · Metavision Arruzafa S.L., Cordoba · Bellvitge University Hospital, L'hospitalet De Llobregat · Hospital La Luz Grupo Quironsalud, Madrid · Hospital Universitario Virgen De La Macarena, Sevilla · Consorci Sanitari de Terrassa, Terrassa · Fundacion Aiken De La Comunitat Valenciana, Valencia · Hospital Universitario Miguel Servet, Zaragoza · Hospital Clinico Universitario Lozano Blesa, Zaragoza
Registry updated 2026-11-05
NCT06635148
A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
Trial Treatment · Phase 2/3 · Janssen Research & Development, LLC
Centro Medico Teknon - Grupo Quironsalud, Barcelona · Centro De Oftalmologia Barraquer S.A., Barcelona · Institut Catala De Retina S.L., Barcelona · Oftalmologia Vistahermosa S.L., Burjassot · Clinica De Oftalmologia De Cordoba S.L., Cordoba · Clinica Baviera S.A., Madrid · Hospital Universitario Fundación Jiménez Díaz, Madrid · Hospital Universitario 12 de Octubre, Madrid · Hospital Universitario Puerta de Hierro de Majadahonda, Majadahonda · Clínica Universidad de navarra, Pamplona · Hospital Universitari General de Catalunya, Sant Cugat del Vallès · University Hospital Virgen Del Rocio S.L., Sevilla · Hospital Clinico Universitario Lozano Blesa, Zaragoza
Registry updated 2026-11-03
NCT07007065
Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD)
Trial Treatment · Phase 3 · AbbVie
Hospital Universitari Vall d'Hebron, Barcelona · Centro De Oftalmologia Barraquer S.A., Barcelona · Instituto Clinic De Oftalmologia, Barcelona · Metavision Arruzafa S.L., Cordoba · Hospital Universitario Donostia, Donostia · Hospital Universitario 12 de Octubre, Madrid · Hospital Universitario Puerta de Hierro de Majadahonda, Majadahonda · Instituto Oftalmologico Fernandez-Vega S.L., Oviedo · Hospital Universitario Virgen De La Macarena, Sevilla · Hospital Universitario Y Politecnico La Fe, Valencia · Hospital Clinico Universitario Lozano Blesa, Zaragoza
Registry updated 2026-10-29
NCT03683251
Extension Study for the Port Delivery System With Ranibizumab (Portal)
Trial Treatment · Phase 3 · Hoffmann-La Roche
Hospital Universitari Vall d'Hebron, Barcelona · Centro Medico Teknon - Grupo Quironsalud, Barcelona · Centro De Oftalmologia Barraquer S.A., Barcelona · Oftalmologia Vistahermosa S.L., Burjassot · Clinica De Oftalmologia De Cordoba S.L., Cordoba · Bellvitge University Hospital, L'hospitalet De Llobregat · Clinica Baviera S.A., Madrid · Hospital Universitario Puerta de Hierro de Majadahonda, Majadahonda · Instituto Oftalmologico Fernandez-Vega S.L., Oviedo · Clínica Universidad de navarra, Pamplona · Hospital Universitari General de Catalunya, Sant Cugat del Vallès
Registry updated 2026-10-27
NCT07064759
Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration
Trial Treatment · Phase 3 · 4D Molecular Therapeutics
Clinica Bonanova de Cirugía Ocular, Barcelona · Miranza Instituto Gomez-Ulla, Santiago de Compostela · Hospital Universitario Virgen Macarena, Seville
Registry updated 2026-10-19
NCT07614776
A Study to Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA® HD (Aflibercept) in Participants With Neovascular Age-related Macular Degeneration
Trial Treatment · Phase 3 · Amgen
Centro De Oftalmologia Barraquer S.A., Barcelona · Hospital Universitari Vall d'Hebron, Barcelona · Hospital La Luz Grupo Quironsalud, Madrid · Hospital Universitario 12 de Octubre, Madrid · Clínica Universidad de navarra, Pamplona · Hospital Universitari General de Catalunya, Sant Cugat del Vallès · Hospital Provincial de Conxo, Santiago de Compostela
Registry updated 2026-10-14
NCT07441642
A Study to Investigate Efficacy and Safety of FWY003 Compared With Placebo in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration
Trial Treatment · Phase 2 · Novartis Pharmaceuticals
Burjassot · Córdoba · Sant Cugat Del V · Santiago Compostela
Registry updated 2026-10-13
NCT07440225
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)
Trial Treatment · Phase 2/3 · EyeBiotech Ltd.
Hospital Universitari Vall d'Hebron - despacho de coordinación de oftalmología. Planta 8, Edifici General, Barcelona · Clinica de Oftalmologia Barraquer, Barcelona · Hospital Universitario Puerta de Hierro - Majadahonda, Madrid
Registry updated 2026-10-02
NCT05481827
ORACLE: A Long-term Follow-up Study to Evaluate the Safety of GT005 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration Treated in a Gyroscope-sponsored Antecedent Study
Trial Treatment · Phase 2 · Gyroscope Therapeutics Limited
Instituto De Microcirugia Ocular Dos S.L., Barcelona · Clinica Baviera S.A., Madrid · Clínica Universidad de navarra, Pamplona
Registry updated 2026-09-28
NCT04663750
Vitrectomy, Subretinal Tissue Plasminogen Activator (TPA) and Intravitreal Gas for Submacular Haemorrhage Secondary to Exudative (Wet) Age-related Macular Degeneration (TIGER).
Trial Treatment · Phase 3 · King's College Hospital NHS Trust
Fundació Hospital Universitari Vall d'Hebron - Institut de Recerca, Barcelona
Registry updated 2026-09-11
2025-524894-17-00
A clinical trial of EYE201/MK-8748 in people with macular degeneration (MK-8748-003)
Trial Treatment · Phase 2/3 · Eyebiotech Limited
Instituto De Microcirugia Ocular Dos S.L., Barcelona · Oftalmologia Vistahermosa S.L., Burjassot · Valles Ophthalmology Research S.L., Sant Cugat Del Valles · Miranza Galicia S.L., Santiago De Compostela · Hospital Clinico Universitario Lozano Blesa, Zaragoza
Registry updated 2026-09-10
NCT06659445
Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
Trial Treatment · Phase 2 · ONL Therapeutics
Centro De Oftalmologia Barraquer S.A., Barcelona · Institut Catala De Retina S.L., Barcelona · Bilboftal S.L., Bilbao · Clinica De Oftalmologia De Cordoba S.L., Cordoba · Hospital Universitario Puerta de Hierro de Majadahonda, Majadahonda · Hospital Universitario Virgen De La Macarena, Sevilla · Fundación de Oftalmología Médica de la Comunitat Valenciana, Valencia · Hospital Universitario Miguel Servet, Zaragoza
Registry updated 2026-09-10
NCT06990269
Phase 2 Study of ADX-038 in Participants With Geographic Atrophy
Trial Treatment · Phase 2 · ADARx Pharmaceuticals, Inc.
Institut Catala De Retina S.L., Barcelona · Centro Medico Teknon - Grupo Quironsalud, Barcelona · Hospital Universitari Vall d'Hebron, Barcelona · Oftalmologia Vistahermosa S.L., Burjassot · Bellvitge University Hospital, L'hospitalet De Llobregat · Hospital Universitario Fundación Jiménez Díaz, Madrid · Fundacion Aiken De La Comunitat Valenciana, Valencia
Registry updated 2026-09-03
NCT07496567
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)
Trial Treatment · Phase 2/3 · EyeBiotech Ltd.
Hospital General de Catalunya, Barcelona · Oftalvist, Burjassot -(Valencia)
Registry updated 2026-08-06
2025-523704-77-00
A clinical trial to learn more about the effects of FWY003 in people with geographic atrophy associated with age-related macular degeneration.
Trial Treatment · Phase 2 · Novartis Pharma AG
Oftalmologia Vistahermosa S.L., Burjassot · Metavision Arruzafa S.L., Cordoba · Hospital Universitari General de Catalunya, Sant Cugat del Vallès · Instituto Oftalmologico Gomez-Ulla S.L., Santiago De Compostela
Registry updated 2026-06-23
2025-524575-22-00
A randomized double-masked, multicenter, 3 arm pivotal Phase 2/3 study to evaluate the efficacy and safety of intravitreal (IVT) EYE201/MK-8748 in participants with neovascular age-related macular degeneration (NVAMD)
Trial Treatment · Phase 2/3 · Eyebiotech Limited
Centro De Oftalmologia Barraquer S.A., Barcelona · Hospital Universitari Vall d'Hebron, Barcelona · Institut Catala De Retina S.L., Barcelona · Hospital Universitario Puerta de Hierro de Majadahonda, Majadahonda
Registry updated 2026-06-12
NCT07403825
Efficacy of Faricimab in Patients With Subretinal Hyper-reflective Material
Trial Treatment · Phase 4 · Biobizkaia Health Research Institute
Hospital Universitario Nuestra Señora del Perpétuo Socorro, Albacete · Clinica Barraquer, Barcelona · Hospital Universitario Basurto, Bilbao · Oftalvist Valencia, Burjassot · Hospital Arruzafa, Córdoba · Hospital Clínico San Carlos, Madrid · Hospital Puerta de Hierro- Majadahonda, Majadahonda · Instituto Oftalmologico Fernandez-Vega, Oviedo · Hospital General Universitario Valencia, Valencia · Hospital Clínico Universitario de Valladolid, Valladolid
Registry updated 2026-05-28
NCT06952452
Pharmacogenomics of antiVEGF in Patients With Age-Associated Macular Degeneration (AMD)
Trial Treatment · Phase 3 · Parc de Salut Mar
Hospital del Mar, Barcelona · Hospital de la Santa Creu i Sant Pau, Barcelona · La Paz Univerity Hospital, Madrid · Hospital Universitario de Canarias, San Cristóbal de La Laguna
Registry updated 2025-11-20
NCT06351657
Personalized Monitoring of Non-foveal, Non-vision Compromising Atrophic Age-related Macular Degeneration With Artificial Intelligence and Identification of Disease Progression
Research · Medical University of Vienna
Fundacio de Recerca Clinic Barcelona-Institut D Investigacions Biomed, Barcelona
Registry updated 2025-05-15
NCT06351670
Personalised Monitoring of Early and Intermediate Age-related Macular Degeneration With Artificial Intelligence and Identification of Disease Progression
Research · Medical University of Vienna
Fundacio de Recerca Clinic Barcelona-Institut D Investigacions Biomed, Barcelona
Registry updated 2025-05-15
NCT06511700
Implementation of the Intravitreal Injection Administered by Nurses
Research · Corporacion Parc Tauli
Corporation Parc Tauli, Sabadell
Registry updated 2025-03-24
NCT03999801
Long-term Follow-Up Study of RGX-314 and Fellow Eye Substudy
Trial Treatment · Phase 2 · AbbVie
Instituto De Microcirugia Ocular Dos S.L., Barcelona · Hospital Clinic de Barcelona, Barcelona · Hospital de la Santa Creu i Sant Pau, Barcelona · Metavision Arruzafa S.L., Cordoba · Complejo Hospitalario Universitario Insular Materno Infantil, Las Palmas de Gran Canaria · Bellvitge University Hospital, L'hospitalet De Llobregat · Clinica Baviera S.A., Madrid · Hospital Universitario 12 de Octubre, Madrid · Hospital Universitario Puerta de Hierro de Majadahonda, Majadahonda · Hospital Provincial de Conxo, Santiago de Compostela
Registry updated 2024-06-17

All Macular degeneration trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error